Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

BCMA anticorps (AA 78-184)

TNFRSF17 Reactivité: Humain ELISA, IHC, Coat, IHC (f) Hôte: Souris Monoclonal BCMA-2366 unconjugated
N° du produit ABIN6936646
  • Antigène Voir toutes BCMA (TNFRSF17) Anticorps
    BCMA (TNFRSF17) (Tumor Necrosis Factor Receptor Superfamily, Member 17 (TNFRSF17))
    Épitope
    • 7
    • 7
    • 7
    • 6
    • 6
    • 5
    • 4
    • 3
    • 3
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 78-184
    Reactivité
    • 55
    • 21
    • 5
    • 1
    • 1
    • 1
    • 1
    • 1
    Humain
    Hôte
    • 43
    • 14
    • 9
    Souris
    Clonalité
    • 42
    • 24
    Monoclonal
    Conjugué
    • 38
    • 9
    • 5
    • 3
    • 3
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Cet anticorp BCMA est non-conjugé
    Application
    • 48
    • 38
    • 15
    • 13
    • 8
    • 7
    • 5
    • 4
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    ELISA, Immunohistochemistry (IHC), Coating (Coat), Immunohistochemistry (Formalin-fixed Sections) (IHC (f))
    Specificité
    The B cell maturation protein (BCMA) is a type I integral membrane protein that belongs to the tumor necrosis factor receptor (TNF-R) superfamily. It is expressed as a 184 amino acid peptide that is expressed only in mature B-lymphocytes and is located on the cis part of the Golgi apparatus. BCMA shares significant homology with TACI (transmembrane activator) within the cysteine-rich domain. TACI has been shown to bind CAML, which induces activation of NFAT (nuclear factor of activated T cells). Both BCMA and TACI have been shown to bind APRIL and TALL-1, which stimulate B cell proliferation in conjunction with other B-cell activators. When overexpressed, TALL-1 stimulates the development of systemic lupus erythaematosus (SLE).
    Réactivité croisée (Details)
    Human.
    Purification
    1.0mg/ml of Ab purified from Bioreactor by Protein A/G.
    Immunogène
    Recombinant human CD269 protein fragment (around aa 78-184) (exact sequence is proprietary)
    Clone
    BCMA-2366
    Isotype
    IgG2c kappa
    Top Product
    Discover our top product TNFRSF17 Anticorps primaire
  • Indications d'application

    Known_Application: ELISA (For coating, order antibody without BSA),Immunohistochemistry (Formalin-fixed) (1-2 μg/mL for 30 minutes at RT),(Staining of formalin-fixed tissues requires heating tissue sections in 10 mM Tris with 1 mM EDTA, pH 9.0, for 45 min at 95°C followed by cooling at RT for 20 minutes), Optimal dilution for a specific application should be determined.

    Positive_Control: NAMALWA cells. Tonsil or gastric carcinoma (IHC).

    Restrictions
    For Research Use only
  • Concentration
    1.0 mg/mL
    Buffer
    Prepared in 10 mM PBS, WITHOUT BSA and Azide.
    Agent conservateur
    Azide free
    Stock
    -20 °C,-80 °C
    Stockage commentaire
    Antibody without azide store at -20 to -80 °C. Antibody is stable for 24 months. Non-hazardous.
    Date de péremption
    24 months
  • Antigène
    BCMA (TNFRSF17) (Tumor Necrosis Factor Receptor Superfamily, Member 17 (TNFRSF17))
    Autre désignation
    CD269 (TNFRSF17 Produits)
    Synonymes
    anticorps TNFRSF17, anticorps BCM, anticorps BCMA, anticorps CD269, anticorps TNFRSF13A, anticorps Tnfrsf13, anticorps Tnfrsf13a, anticorps TNF receptor superfamily member 17, anticorps tumor necrosis factor receptor superfamily, member 17, anticorps Tnfrsf17, anticorps TNFRSF17
    Sujet
    B-cell maturation protein, BCMA, CD269, TNR17, Tumor necrosis factor receptor superfamily member 17 (TNFRSF17),CD269 / TNFRSF17 / BCMA (B-Cell Maturation Protein)
    Cellular localisation: Cell Surface
    Poids moléculaire
    20kDa
    ID gène
    608, 2556
    UniProt
    Q02223
Vous êtes ici:
Support technique